184 related articles for article (PubMed ID: 18325492)
1. Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers.
Verma M; Martin HJ; Haq W; O'Connor TR; Maser E; Balendiran GK
Eur J Pharmacol; 2008 Apr; 584(2-3):213-21. PubMed ID: 18325492
[TBL] [Abstract][Full Text] [Related]
2. Cancer biomarker AKR1B10 and carbonyl metabolism.
Balendiran GK; Martin HJ; El-Hawari Y; Maser E
Chem Biol Interact; 2009 Mar; 178(1-3):134-7. PubMed ID: 19028477
[TBL] [Abstract][Full Text] [Related]
3. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
Nakano T; Petrash JM
Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
[TBL] [Abstract][Full Text] [Related]
4. Fibrates inhibit aldose reductase activity in the forward and reverse reactions.
Balendiran GK; Rajkumar B
Biochem Pharmacol; 2005 Nov; 70(11):1653-63. PubMed ID: 16226225
[TBL] [Abstract][Full Text] [Related]
5. Fibrates in the chemical action of daunorubicin.
Balendiran GK
Curr Cancer Drug Targets; 2009 May; 9(3):366-9. PubMed ID: 19442055
[TBL] [Abstract][Full Text] [Related]
6. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
[TBL] [Abstract][Full Text] [Related]
7. Involvement of cysteine residues in catalysis and inhibition of human aldose reductase. Site-directed mutagenesis of Cys-80, -298, and -303.
Petrash JM; Harter TM; Devine CS; Olins PO; Bhatnagar A; Liu S; Srivastava SK
J Biol Chem; 1992 Dec; 267(34):24833-40. PubMed ID: 1332968
[TBL] [Abstract][Full Text] [Related]
8. WY 14,643 inhibits human aldose reductase activity.
Klemin S; Calvo RY; Bond S; Dingess H; Rajkumar B; Perez R; Chow L; Balendiran GK
J Enzyme Inhib Med Chem; 2006 Oct; 21(5):569-73. PubMed ID: 17194029
[TBL] [Abstract][Full Text] [Related]
9. Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.
Huang L; He R; Luo W; Zhu YS; Li J; Tan T; Zhang X; Hu Z; Luo D
Recent Pat Anticancer Drug Discov; 2016; 11(2):184-96. PubMed ID: 26844556
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
11. Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids.
Endo S; Matsunaga T; Mamiya H; Ohta C; Soda M; Kitade Y; Tajima K; Zhao HT; El-Kabbani O; Hara A
Arch Biochem Biophys; 2009 Jul; 487(1):1-9. PubMed ID: 19464995
[TBL] [Abstract][Full Text] [Related]
12. AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.
Zhong L; Shen H; Huang C; Jing H; Cao D
Toxicol Appl Pharmacol; 2011 Aug; 255(1):40-7. PubMed ID: 21640744
[TBL] [Abstract][Full Text] [Related]
13. Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase.
Giménez-Dejoz J; Kolář MH; Ruiz FX; Crespo I; Cousido-Siah A; Podjarny A; Barski OA; Fanfrlík J; Parés X; Farrés J; Porté S
PLoS One; 2015; 10(7):e0134506. PubMed ID: 26222439
[TBL] [Abstract][Full Text] [Related]
14. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
Carper DA; Hohman TC; Old SE
Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
[TBL] [Abstract][Full Text] [Related]
15. The effect of non-enzymatic glycation on recombinant human aldose reductase.
Yamaoka T; Oda A; Bannai C; Itakura M; Yamashita K
Diabetes Res Clin Pract; 1995 Mar; 27(3):165-9. PubMed ID: 7555597
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
[TBL] [Abstract][Full Text] [Related]
17. Modification of aldose reductase by S-nitrosoglutathione.
Chandra A; Srivastava S; Petrash JM; Bhatnagar A; Srivastava SK
Biochemistry; 1997 Dec; 36(50):15801-9. PubMed ID: 9398310
[TBL] [Abstract][Full Text] [Related]
18. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics.
Martin HJ; Breyer-Pfaff U; Wsol V; Venz S; Block S; Maser E
Drug Metab Dispos; 2006 Mar; 34(3):464-70. PubMed ID: 16381663
[TBL] [Abstract][Full Text] [Related]
20. Modulation of activity and inhibitor sensitivity of rabbit aldose reductase-like protein (AKR1B19) by oxidized glutathione and SH-reagents.
Endo S; Fujimoto A; Kumada S; Matsunaga T; Ohno S; Mano J; Tajima K; El-Kabbani O; Hara A
Chem Biol Interact; 2013 Feb; 202(1-3):146-52. PubMed ID: 23261715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
